Penghua CNI HK Connect Innovative Drug Index ETF

Penghua CNI HK Connect Innovative Drug Index ETF is offered by Penghua, a leading player in the field of passive investments.

European investors may incur additional costs for currency exchange and transaction fees.

No, Penghua CNI HK Connect Innovative Drug Index ETF does not comply with the EU UCITS investor protection directives.

Penghua CNI HK Connect Innovative Drug Index ETF tracks the performance of the CNI HK Connect Innovative Drug Index - CNY - Benchmark TR Net.

Penghua CNI HK Connect Innovative Drug Index ETF is domiciled in CN.

The fund was launched on 9/2/2025.

The Penghua CNI HK Connect Innovative Drug Index ETF mainly invests in Healthcare companies.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.